Biotransformation of the Antimelanoma Agent Betulinic Acid by Bacillus megaterium ATCC 13368
AUTOR(ES)
Chatterjee, Parnali
FONTE
American Society for Microbiology
RESUMO
Microbial transformation of the antimelanoma agent betulinic acid was studied. The main objective of this study was to utilize microorganisms as in vitro models to predict and prepare potential mammalian metabolites of this compound. Preparative-scale biotransformation with resting-cell suspensions of Bacillus megaterium ATCC 13368 resulted in the production of four metabolites, which were identified as 3-oxo-lup-20(29)-en-28-oic acid, 3-oxo-11α-hydroxy-lup-20(29)-en-28-oic acid, 1β-hydroxy-3-oxo-lup-20(29)-en-28-oic acid, and 3β,7β,15α-trihydroxy-lup-20(29)-en-28-oic acid based on nuclear magnetic resonance and high-resolution mass spectral analyses. In addition, the antimelanoma activities of these metabolites were evaluated with two human melanoma cell lines, Mel-1 (lymph node) and Mel-2 (pleural fluid).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=92230Documentos Relacionados
- Characterization of the penicillin G acylase from Bacillus megaterium ATCC 14945
- Dielectric characterization of forespores isolated from Bacillus megaterium ATCC 19213.
- Bacteriocin from Bacillus megaterium ATCC 19213: comparative studies with megacin A-216.
- BIOSYNTHESIS OF DIPICOLINIC ACID IN BACILLUS MEGATERIUM1
- Cloning, Expression, and Catabolite Repression of a Gene Encoding β-Galactosidase of Bacillus megaterium ATCC 14581
